Clazosentan in Preventing the Occurrence of Cerebral Vasospasm Following an Aneurysmal Subarachnoid Hemorrhage (aSAH)
Clinical trial NCT00111085 · COMPLETED
Trial details
- NCT number
- NCT00111085
- Sponsor
- Idorsia Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-01-10
- Primary completion
- 2006-03-30
- Enrollment
- 413
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.